Association of bile duct and gallbladder diseases with the use of incretin-based drugs in patients with type 2 diabetes mellitus
Tsai J-C, Perrella MA, Yoshizumi M, Hsieh C-M, Haber E, Schlegel R, and Lee M-E (1994)
Cells with downregulated GPX4 expression are more susceptible to ferroptosis, whereas high levels of GPX4 can effectively suppress this process [34, 35]
This means that our former runner-up here, PureBulk, is the undisputed top pick in our estimation
Specifically, the ELIXA (lixisenatide) trial studied patients with T2DM who had recent acute coronary syndrome and found that the addition of lixisenatide to conventional therapy did not result in a significant difference in cardiovascular endpoints relative to placebo (Table 1) [56]